SPAC Update – August 7

– ARTE announced a business combination with Danam Health
– RMGC stockholders approved deadline extension to Feb 9 2024, 283k shares (30.8%) redeemed, 636k shares remain
– NOVV stockholders approved deadline extension to Aug 10 2024, 253k shares (14.0%) redeemed, 1.6 million shares remain, extended deadline to Sept 10, added $70k to trust account
– PEGR stockholders approved deadline extension to May 2 2024, 15.5 million shares (58.8%) redeemed, 10.9 million shares remain, NAV $10.41
– FLAG filed 424b3 for Calidi Biotherapeutics deal, vote Aug 22, NAV $10.49
– CFFE filed DEFM14a for XBP Europe deal, vote Aug 24
– KWAC filed DEF14a to extend deadline to Nov 24 2023, vote Aug 17
– DKDCA filed DEF14a to extend deadline to May 11 2024, vote Aug 11, NAV $11.10
– DKDCA filed PRER14a to extend deadline to May 11 2024, vote Aug 11, NAV $11.10
– QOMO filed PRE14a to amend charter to allow a business combination with a China-based target
– FSNB filed PRE14a to extend deadline to Mar 2 2023 (sic), vote in Aug
– GFOR filed S-4/a for NKGen Biotech, NAV $10.36
– RWOD filed S-4 for ANEW MEDICAL deal
– LHC filed S-4/a for World View deal
– FRLA extended deadline to Sept 5 2023, added $100k to trust account
– SZZL extension vote
– ASPA extension vote
– GSD extension vote
– OXAC deal vote
– EMCG redemption
– HHLA redemption